Wen Xin Ke Li
Wen Xin Ke Li (WXKL) is a patented Chinese medication extensively utilised in China as an adjuvant therapy for individuals with cardiovascular issues, particularly for the management of atrial fibrillation.
Recent Insights
Related Topics
Research Articles
Published research studies are articles that present the findings of original research that has undergone a peer-review process and has been made publicly available in scholarly journals, books or other media.
An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation
2022 May 30 Evidence-Based Complementary and Alternative Medicine Wang Y, Liu Y, Yan X, Wang D
Wenxin Keli (WXKL) may be clinically efficacious and safe for the treatment of atrial fibrillation.
Systematic Review Wen Xin Ke Li Huang JingProtective effects of Wenxin Keli against cardiac arrhythmias (Review)
2020 Apr 06 World Academy of Sciences Journal Dahal S, Gong M, Guo S, Tse G, Liu T
Based on the results from various studies, it has minimal side‑effects and is less proarrhythmic with an efficacy that matches that of western drugs. Varying effects of WXKL on physiological functions have opened novel doors in managing arrhythmias.
Review Article Cardiac Arrhythmia Wen Xin Ke Li
The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation
2016 Jan International Journal of Cardiology Liu Y, Zhang Z, Yang Y, Zhang N, Li G, Liu T
In clinical practice, WXKL can markedly improve the patients' symptoms and that it have significant effects on ameliorating different types of arrhythmias.Therefore, we propose WXKL, as a novel Chinese herb medicine may have a potential role in the prevention and treatment of AF.
Network Pharmacology Atrial Fibrillation Cardiac Arrhythmia
The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions
2015 Oct 05 Chinese Medical Journal Hua W, Gao RL, Zhao BC, Wang J, Chen XH, Cai C, et al.
Wenxin Keli treatment effectively reduced the overall number of premature ventricular contractions (PVCs) and alleviated PVC-related symptoms in patients without structural heart diseases and had no severe side effects.
Randomised Controlled Trial Premature Ventricular Contractions Wen Xin Ke LiReview Articles
Review articles summarise and critically evaluate the current state of research on a specific topic or field by synthesising multiple primary research studies.
An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation
2022 May 30 Evidence-Based Complementary and Alternative Medicine Wang Y, Liu Y, Yan X, Wang D
Wenxin Keli (WXKL) may be clinically efficacious and safe for the treatment of atrial fibrillation.
Systematic Review Wen Xin Ke Li Huang JingProtective effects of Wenxin Keli against cardiac arrhythmias (Review)
2020 Apr 06 World Academy of Sciences Journal Dahal S, Gong M, Guo S, Tse G, Liu T
Based on the results from various studies, it has minimal side‑effects and is less proarrhythmic with an efficacy that matches that of western drugs. Varying effects of WXKL on physiological functions have opened novel doors in managing arrhythmias.
Review Article Cardiac Arrhythmia Wen Xin Ke LiClinical Trials
Clinical trials are research studies that involve people and are conducted to evaluate the safety and efficacy of new treatments or interventions, such as drugs, medical devices, or behavioural therapies.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.